Apply the four published expert-consensus clinical scenarios to manage GI adverse events in complex GLP-1 receptor agonist patients — persistent nausea mid-titration, GERD/heartburn after up-titration, elderly with sarcopenia risk, and insulin-treated elderly with CKD plus diarrhoea. Use when a clinician describes a patient resembling one of these archetypes, or asks "how to manage GLP-1 in an elderly patient with CKD", "patient on liraglutide developed reflux", "sarcopenia worry on semaglutide in 80-year-old", or "persistent nausea on semaglutide despite escalation". Grounded in Gorgojo-Martínez 2023 Table 4.
日本語の概要は準備中です。原文の説明を表示しています。
dromlakhani/MD2SKILL☆ 132026年10月5日 更新
Elderly Care Tech Specialist IA — Expert en technologies pour personnes âgées (fall detection, medication reminders, social connection, accessibility)
日本語の概要は準備中です。原文の説明を表示しています。
ziri22/agency-roster☆ 62026年7月1日 更新
Decide whether commonly-excluded patients (eating disorders, elderly ≥75, upper GI disease) can actually receive a GLP-1 receptor agonist. Use when a clinician asks "can I give semaglutide to a patient with binge eating disorder / anorexia / bulimia", "is liraglutide safe in an 80-year-old", "GLP-1 with GERD or chronic gastritis", "GLP-1 in sarcopenic elderly", or anytime a patient is being ruled out for GLP-1 therapy based on a perceived contraindication. Grounded in Gorgojo-Martínez 2023 §6 (Myths or Reality).
日本語の概要は準備中です。原文の説明を表示しています。
dromlakhani/MD2SKILL☆ 132026年10月5日 更新
Expert en technologies de soin aux personnes âgées avancées (fall detection, medication reminders, social connection, accessibility)
日本語の概要は準備中です。原文の説明を表示しています。
ziri22/agency-roster☆ 62026年7月1日 更新
Applies the epidemiological reasoning and population-health frameworks of Albert Hofman (Harvard epidemiologist, Rotterdam Study). Trigger this skill whenever you are analyzing public health strategies, preventive medicine, cohort study design, cardiovascular or neurodegenerative disease risks, or healthy aging. Use it when evaluating whether to use population-wide interventions versus individual screening, assessing risk factors in elderly populations, or tracing adult chronic diseases back to early-life or fetal origins.
日本語の概要は準備中です。原文の説明を表示しています。
K-Dense-AI/mimeographs☆ 1302026年8月19日 更新